About Tianjin Tianyao Pharmaceuticals Company

The company is a holding subsidiary of the listed company Jinyao Pharmaceutical. It is a biomedical enterprise attracting investment and key support from the Xiangyang Municipal Committee and Municipal Government. It is a high-tech enterprise, a key manufacturer of essential drugs and drugs in acute shortage in central China, and an invisible champion enterprise in the pillar industry segment in Hubei Province. It was included in the national list of key guarantee enterprises for COVID-19 prevention and control in 2020 (first batch), specializing in the production and sale of small-volume injections and large-volume injections. Mainly engaged in R&D, production and sales of steroidal hormones and amino acid raw materials and formulations. The main products include dexamethasone series, prednisone series, methylprednisolone series, betamethasone series, etc., more than 40 types of steroidal hormone raw materials, 25 kinds of amino acid raw materials, and 17 dosage forms of drugs such as injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalants, and tablets. The company is a high-tech enterprise recognized by the country and the chairman unit of the National Steroid Hormone Industry Association. It is the first batch of raw materials and formulation manufacturers in Tianjin to obtain the GMP certificate for corticosteroid raw materials and the first batch of raw materials and formulations in Tianjin to pass the national GMP certification; the subsidiary Jinyao Pharmaceutical, as a leading science and technology enterprise in Tianjin, has always been committed to becoming a domestic research and development base for corticosteroid drugs. Currently, the company and Jinyao Pharmaceutical were rated as the “2019 Top 100 Enterprises in Tianjin Economic and Technological Development Zone” and won the “Tianjin City Top 100 Enterprises” Famous trademark” “Tianjin City Heavy Honors such as “Click to cultivate and develop export brands”.